For Healthcare Professionals: Benign Blood Disorders

The specialists on our Hematology Disease Management Team provide care for a spectrum of common and rare cancers that develop in the bone marrow, blood, and lymph nodes. The team provides high-dose chemotherapy treatments for lymphoma, leukemia, amyloidosis, and multiple myeloma in addition to the management of blood disorders characterized by the imbalanced production of certain types of blood cells.

We provide multidisciplinary care to more than 100 patients with myelodysplasia annually, for example, and have been designated a Center of Excellence by the Myelodysplastic Syndromes Foundation in recognition of our authority in treating this cancer. Our physicians also have expertise in screening and diagnosing familial amyloidosis, and have had notable success in using stem cell transplantation for the condition.

Refering a Patient

Call 866-218-8132
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday possible today.

Pictured: Gerald Soff & Rekha Parameswaran
Benign Blood Disorder Information for Your Patients

The Memorial Sloan Kettering approach to managing benign blood disorders in patient-friendly language.

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Pictured: Gerald A. Soff
Romiplostim in Chemotherapy-Induced Thrombocytopenia (2011 ASH Conference)

Gerald Soff, Chief of Memorial Sloan Kettering’s Hematology Service, describes the use of weekly romiplostim in patients with prolonged isolated thrombocytopenia.